Effect of Metformin and Myo-inositol in Patients with Polycystic Ovary Syndrome
Abstract
Background: Polycystic Ovary Syndrome (PCOS), also known as Stein-Leventhal syndrome, is a reproductive hormone condition. It causes irregular ovulation, nonexistent periods, insulin resistance, and androgenic hormone overproduction. Hormonal imbalances may cause extra hair growth, acne, hair loss, and greasy skin. If you suspect PCOS, visit a doctor. It may have a major influence on your health. Aim: To determine the adjuvant effect of metformin & myo-inositol in polycystic ovary syndrome patients. Methods: This research was performed on three subgroups of 100 women with PCO (according to the Rotterdam criteria, ESHRE/ASRM 2004) Group I (50 women): who received metformin (500 mg) + (2 gm myo-inositol) in the evening for 3 months.Group II (50 women): obtained metformin 500 mg (cidophage 500 mg) 3 times daily for 3 months. All females involved in the research were submitted to: Full history Taking (Personal, Medical, Menstrual and General history) and Physical examination. Result: There was no statistically significant distinction in the baseline characteristics of both groups. Transvaginal Ultrasonography "Ovarian size" post-treatment showed a statistically significant distinction among both Groups in terms of normal ovarian size. The variance in pregnancy rates among the 2 groups was statistically highly significant. Also there was a statistical significant correlation among pregnancy rates according to transvaginal ultrasound regarding ovarian size in all patients.…
Read the paper
Related studies
- Increased expression of circulating miRNA-93 in women with polycystic ovary syndrome may represent a novel, non-invasive biomarker for diagnosis
- Identification of key genes associated with polycystic ovary syndrome (PCOS) and ovarian cancer using an integrated bioinformatics analysis
- Identification of key pathways and genes in polycystic ovary syndrome via integrated bioinformatics analysis and prediction of small therapeutic molecules
- Regulation of Androgen Receptor Expression Alters AMPK Phosphorylation in the Endometrium: In Vivo and In Vitro Studies in Women with Polycystic Ovary Syndrome
- Effect of oral administration of low-dose follicle stimulating hormone on hyperandrogenized mice as a model of polycystic ovary syndrome
- Systems pharmacology to investigate the interaction of berberine and other drugs in treating polycystic ovary syndrome
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.